FDA inspection
McGuff Pharmaceuticals, Inc.: FDA inspection ending Jan 26, 2024
FDA inspection 1228033 · Official Action Indicated (OAI) · Santa Ana, CA
Key facts
| Inspection ID | 1228033 |
|---|---|
| Firm | McGuff Pharmaceuticals, Inc. |
| FEI number | 2022073 |
| Address | 2921 W Macarthur Blvd Ste 141 |
| City | Santa Ana |
| State | CA |
| ZIP | 92704-6995 |
| Fiscal year | 2024 |
| Inspection end date | Jan 26, 2024 |
| Classification | Official Action Indicated (OAI) |
| Project area | New Drug Evaluation |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data